Thomas Scientific Signs Distribution Deal For MaximBio’s Covid-19 Test
Connect with us

Plato Vertical Search

Medical Devices

Thomas Scientific signs distribution deal for MaximBio’s Covid-19 test

The antigen test is designed to detect SARS-CoV-2 proteins from nasal swab samples.

The post Thomas Scientific signs distribution deal for MaximBio’s Covid-19 test appeared first on Medical Device Network.

Diagnostic healthcare company Maxim Biomedical (MaximBio) has signed a marketing and distribution agreement with Thomas Scientific for its ClearDetect COVID-19 Antigen Home Test.

The antigen test received Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) this month.

It is designed to detect SARS-CoV-2 proteins from nasal swab samples and provide results within 15 minutes.

The test uses Lateral Flow Assay (LFA) technology and can be performed easily at home without requiring equipment or a reader.

The ClearDetect COVID-19 Antigen Home Test involves only three components, specifically, a swab, test strip and test tube that comes pre-filled with sample buffer.

MaximBio stated that the test achieved 86.9% positive agreement and 98.9% negative agreement in comparison to a EUA authorised PCR method.

Content from our partners
“Everything is custom”: Behind the scenes of medical wire solutions
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials

It detected 100% of live virus Omicron samples when assessed by the National Institutes of Health (NIH) with positive specimens for the Omicron variant.

The antigen home test detected the variant at a higher dilution compared to the other two EUA-approved antigen tests in the same study.

MaximBio chief commercial officer Anthony Morrison said: “Their dedication to provide the best products with personal, efficient service makes them an ideal partner for MaximBio as we team up to help meet the growing demand for Covid-19 testing.”

The ClearDetect COVID-19 Antigen Home Test will be available in two kit formats, either a two test pack for at-home use or bulk 25-test pack for healthcare settings, workplaces, schools and other high-volume testing scenarios.

Under the deal, Thomas Scientific will offer both kit formats and plans to price them competitively.

Furthermore, MaximBio is increasing its production to meet Covid-19 testing demand.

Related Companies
Thomas Scientific signs distribution deal for MaximBio’s Covid-19 test

Thomas Scientific signs distribution deal for MaximBio’s Covid-19 test

Thomas Scientific signs distribution deal for MaximBio’s Covid-19 test

Related Streams

Aviation

Qantas Boeing 787-9 Dreamliner (James D Morgan/Qantas) The first Qantas non-stop flight between Perth and London will take off on Monday for the first...

Aviation

Qantas Boeing 787-9 Dreamliner (James D Morgan/Qantas) The first Qantas non-stop flight between Perth and London will take off on Monday for the first...

Forex

Off the coast of north-eastern Japan, Magnitude 5.5 earthquake Weekend – ECB President Lagarde says crypto assets are ‘worth nothing,’ Monkeypox – High-risk contacts...

Forex

Off the coast of north-eastern Japan, Magnitude 5.5 earthquake Weekend – ECB President Lagarde says crypto assets are ‘worth nothing,’ Monkeypox – High-risk contacts...